NOXXON PHARMA NV (ALNOX.PA) Stock Earnings & Estimates
EPA:ALNOX - NL0012044762 - Common Stock
0.041 EUR
-0.01 (-18%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 25K | 43K 72.00% | 83K 93.02% | 343.33K -100.00% | 5.15M | -100.00% | |||||||
| EBITDA YoY % growth | -11.79M | -9.903M 16.01% | -5.802M 41.41% | -5.15M 18.99% | N/A 2.13% | -5.116M 12.61% | N/A -43.28% | -14.42M -132.47% | -21.63M -61.54% | -2.06M 90.48% | -2.405M -16.74% | -2.891M -20.24% | |
| EBIT YoY % growth | -12.069M | -10.121M 16.14% | -6.142M 39.31% | -4.697M 23.01% | -5.047M 2.30% | 161.37K 11.90% | N/A -43.00% | -14.42M -131.27% | -21.63M -60.70% | -2.06M 90.48% | -2.405M -16.74% | -2.891M -20.24% | |
| Operating Margin | -48,276.00% | -23,537.21% | -7,400.00% | -1,368.01% | N/A | N/A | N/A | N/A | -420.00% | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -2.18 64.07% | -1.05 51.89% | 0.92 187.25% | -1.60 -274.16% | -0.27 83.23% | -0.32 -19.23% | -0.09 70.97% | -0.11 -22.20% | -0.14 -25.87% |
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
| Period | Reported | Estimate | Difference | Surprise |
|---|
Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in EUR, while estimates are .
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |